TTRX — Turn Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- $107.89m
- $104.70m
Annual cashflow statement for Turn Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG |
| Status: | Final | Final |
| Net Income/Starting Line | -4.29 | -3.08 |
| Depreciation | ||
| Amortisation | ||
| Non-Cash Items | 1.93 | 1.47 |
| Other Non-Cash Items | ||
| Changes in Working Capital | 1.1 | 0.172 |
| Change in Prepaid Expenses | ||
| Change in Other Assets | ||
| Change in Accounts Payable | ||
| Change in Accrued Expenses | ||
| Change in Payable / Accrued Expenses | ||
| Change in Other Liabilities | ||
| Net Change in Other Assets & Liabilities | ||
| Other Operating Cash Flow | ||
| Cash from Operating Activities | -1.21 | -1.38 |
| Capital Expenditures | -0.018 | -0.044 |
| Purchase / Acquisition of Intangibles | ||
| Cash from Investing Activities | -0.018 | -0.044 |
| Net Issuance / Retirement of Stock | ||
| Cash from Financing Activities | 0.35 | 0.5 |
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | -0.874 | -0.922 |